2.9. Administration of meglumine antimoniate (Glucantime®)

Patients diagnosed with CL accepted treatment with meglumine antimoniate (Glucantime®). Glucantime is marketed in 5 mL ampules containing 1.5 g of N-methyl-glucamine antimoniate, which corresponds to 425 mg of Sb51. Treatment consisted in one ampule by intramuscular injection per day until healing [19].
